Page 23 - Tom Van News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Yacht Harbour May 17, 2021 275 Facebook Google+ Australian yachts can come to New Zealand but owners’ family and friends who either have an Australian passport or have been allowed into Australia can fly to New Zealand through the Australian/New Zealand trans-Tasman bubble and join their vessel. Key points for superyacht visitors.  Destination New Zealand – 24-months temporary entry of vessels A cruising yacht is entitled to visit New Zealand for up to 24 months without the need for the yacht to be imported to New Zealand. A Temporary Import Entr...

Wednesday, May 5, 2021 Robert “Steve” Dolph, age 55 of Cherokee, IA, passed away Thursday, April 29, 2021, at his home in Cherokee. Memorial services will be held at 10:30 a.m. Thursday, May 6, 2021, at the Greenwood-Schubert Funeral Home in Cherokee. Monsignor Kenneth Seifried will officiate. A private family burial will be at Oak Hill Cemetery in Cherokee. Public visitation will begin at 2:00 p.m. Wednesday, with family present from 5:00-7:00 p.m. Wednesday night at the Greenwood-Schubert Funeral home in Cherokee. Steve’s service will be broadcast live on the Greenwood-Schubert website....

Yachting Monthly Sam Fortescue examines how renewable energy afloat is benefitting from technical developments in other sectors Oceanvolt's electric drives feature a clean display that can tell you exactly how much electricity the system is consuming under power or generating under sail. Credit: Richard Langdon/Ocean Images As the rest of the world grapples with decarbonisation, the sailing community is benefitting from the various technical developments made in other sectors, and now has more options to use renewable energy afloat. It is now simpler to harvest and stor...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. iTeos Therapeutics Announces New Preliminary Data Indicating Clinical Activity with its ... iTeos Therapeutics Inc.April 10, 2021 GMT Initial data from the Phase 1 dose escalation part of the Phase 1/2a trial in adult patients with advanced solid tumors indicated EOS-448 was generally well tolerated with no dose-limiting toxicities observed EOS-448 showed preliminary signs of clinical activity as a monotherapy, including a partial response in one pembrolizumab-resistant melanoma patient, and stable ...

Share: Initial data from the Phase 1 dose escalation part of the Phase 1/2a trial in adult patients with advanced solid tumors indicated EOS-448 was generally well tolerated with no dose-limiting toxicities observed EOS-448 showed preliminary signs of clinical activity as a monotherapy, including a partial response in one pembrolizumab-resistant melanoma patient, and stable disease in multiple patients EOS-448 reduced TIGIT + suppressive T regulatory cells and CD8 T cells considered to be exhausted at all tested doses, indicating engagement of FcγR, an essential component in many immune s...